Standard BioTools Inc.
LABNASDAQHealthcareMedical Devices
As of Oct 15, 2026 close
- Market cap
- $257.36M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.63$1.72
- Volume (live)
- -
- Avg. volume (3M)
- 1.14M
Standard BioTools (LAB) Stock Price & Financial Analysis
Standard BioTools Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.63 - $0.67 |
|---|---|
| 52-Week High | $1.72 |
| 52-Week Low | $0.63 |
| Open | $0.63 |
| Volume (last close) | 485.72K |
| Average Volume (3M) | 1.14M |
| Revenue (TTM) | 84.60M |
|---|---|
| Net Income (TTM) | -87.38M |
| Free Cash Flow (TTM) | -82.58M |
| EPS (TTM) | −$0.23 |
| Profit Margin | -103.29% |
| Operating Margin | -74.04% |
| Return on Equity (ROE) | -16.18% |
| Debt to Equity | 0.05 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 257.36M |
|---|---|
| Shares Outstanding | 390.88M |
| Price to Sales (P/S) | 3.04 |
| Price to Book (P/B) | 0.48 |
| EV/EBITDA | -0.21 |
| 50-Day MA | $0.71 |
|---|---|
| 200-Day MA | $0.96 |
| 1-Year Change | −48.96% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Standard BioTools at a Glance
As of the Oct 15, 2026 close, Standard BioTools (LAB) has a market capitalization of $257.36M. The stock trades at 3.0× sales. Over the trailing twelve months it lost $87.38M on revenue of $84.60M and burned $82.58M of free cash flow. Revenue fell 23.6% year over year.
As of its latest reported balance sheet, it holds $270.03M in cash and securities against $28.09M of debt, a net cash position of $241.94M.
Standard BioTools does not currently pay a dividend.
The share price is down 49.0% over the past year. At $0.66 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.63 to $1.72, below its 200-day moving average of $0.96.
Frequently Asked Questions About Standard BioTools
What is the current stock price for LAB?
As of the Oct 15, 2026 close, LAB stock trades at $0.66. The 52-week range is $0.63–$1.72, with a day range of $0.63–$0.67.
What is the P/E ratio for LAB?
The P/E ratio (Price-to-Earnings) for LAB is shown in the Key Statistics section. This valuation metric helps compare Standard BioTools Inc. to industry peers.
Does LAB pay dividends?
Standard BioTools does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LAB?
Analyst ratings and recommendations for LAB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of LAB?
As of the Oct 15, 2026 close, Standard BioTools's market capitalization is $257.4M, classifying it as a micro-cap company. Standard BioTools operates in the Healthcare sector within the Medical Devices industry.